Dipirona: ¿Beneficios subestimados o riesgos sobredimensionados? Revisión de la literatura

Buitrago-González, Tatiana Patricia; Calderón-Ospina, Carlos Alberto; Vallejos-Narváez, Alvaro.
Rev. colomb. ciencias quim. farm ; 43(1): 173-195, Jan.-June 2014. ilus, tab
Artículo en Español | LILACS | ID: lil-729558

Documentos relacionados

  1. [Adequacy of the safety of metamizole and agranulocytosis].
  2. [Agranulocytosis after use of metamizole - an underestimated risk?]
  3. [Recommendations for the perioperative use of dipyrone : Expert recommendation of the working group on acute pain of the German Pain Society, the scientific working group on pain medicine of the German Society for Anesthesiology and Intensive Care Medicine and the surgical working group on acute pain of the German Society for Surgery with participation of representatives of the Drug Commission of the German Medical Association].
  4. Is it time to restrict the clinical use of dipyrone?
  5. Metamizole (dipyrone)-induced agranulocytosis: Does the risk vary according to ethnicity?
  6. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis].
  7. [Metamizol: current status in Dutch practice].
  8. [Recommendations for the perioperative use of dipyrone : Expert recommendation of the working group on acute pain of the German Pain Society, the scientific working group on pain medicine of the German Society for Anesthesiology and Intensive Care Medicine and the surgical working group on acute pain of the German Society for Surgery with participation of representatives of the Drug Commission of the German Medical Association].
  9. Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose.
  10. Dipyrone-related granulocytopenia. Case report